Replimune Group, Inc. (REPL)

8.07 +1.03 (+14.63%) USD  |  NASDAQ  |  Mar 06, 16:00
9.21 +1.14 (+14.13%) After-Hours: 20:00
More

Replimune Group Income Tax Paid Supplemental Data (Annual)

Income Tax Paid Supplemental Data (Annual) Chart

View Income Tax Paid Supplemental Data (Annual) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Income Tax Paid Supplemental Data (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Income Tax Paid Supplemental Data (Annual) Range, Past 5 Years

View Income Tax Paid Supplemental Data (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Income Tax Paid Supplemental Data (Annual) Benchmarks

View Income Tax Paid Supplemental Data (Annual) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
REGENXBIO, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade